Proton pump inhibitors do not contribute to dementia or Alzheimer's disease

(American Geriatrics Society) Noting that the prescription of proton pump inhibitors is on the rise among middle-aged and older adults, a team of researchers designed a new study to examine PPIs and the risk of dementia, mild cognitive impairment, and Alzheimer's disease. They published their study in the Journal of the American Geriatrics Society.